• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Haemoglobin A1 and diabetes mellitus.

作者信息

Gonen G, Rubenstein A H

出版信息

Diabetologia. 1978 Jul;15(1):1-8. doi: 10.1007/BF01219319.

DOI:10.1007/BF01219319
PMID:355029
Abstract
摘要

相似文献

1
Haemoglobin A1 and diabetes mellitus.血红蛋白A1与糖尿病
Diabetologia. 1978 Jul;15(1):1-8. doi: 10.1007/BF01219319.
2
Haemoglobin AIc concentrations after initial insulin treatment for newly discovered diabetes.新发现糖尿病患者初始胰岛素治疗后的糖化血红蛋白浓度
Br Med J. 1978 Mar 25;1(6115):741-2. doi: 10.1136/bmj.1.6115.741.
3
Glycosylated haemoglobin concentrations and clinitest results in insulin-dependent diabetes.胰岛素依赖型糖尿病患者的糖化血红蛋白浓度及尿糖定性试验结果
Lancet. 1977 Dec 3;2(8049):1156-7. doi: 10.1016/s0140-6736(77)91541-0.
4
Glycosylated hemoglobin in diabetes mellitus: correlations with fasting plasma glucose, serum lipids, and glycosuria.糖尿病中的糖化血红蛋白：与空腹血糖、血脂及糖尿的相关性
Diabetes Care. 1980 Jul-Aug;3(4):508-14. doi: 10.2337/diacare.3.4.508.
5
Metabolic control of diabetes mellitus during routine management at an out-patient department.
Acta Med Scand. 1980;207(6):475-81. doi: 10.1111/j.0954-6820.1980.tb09757.x.
6
Mean amplitude of glycemic excursions, a measure of diabetic instability.血糖波动平均幅度，一种衡量糖尿病不稳定程度的指标。
Diabetes. 1970 Sep;19(9):644-55. doi: 10.2337/diab.19.9.644.
7
On measuring the adequacy of diabetes regulation: comparison of continuously monitored blood glucose patterns with values at selected time points.关于测量糖尿病控制的充分性：连续监测的血糖模式与选定时间点的值的比较。
Diabetologia. 1974 Apr;10(2):139-43. doi: 10.1007/BF01219670.
8
Haemoglobin A1: An indicator of the metabolic control of diabetic patients.糖化血红蛋白A1：糖尿病患者代谢控制的一项指标。
Lancet. 1977 Oct 8;2(8041):734-7. doi: 10.1016/s0140-6736(77)90237-9.
9
Discrepancies between glycosuria and home estimates of blood glucose in insulin-treated diabetes mellitus.胰岛素治疗的糖尿病患者中糖尿与血糖自我估计值之间的差异。
Diabetes Care. 1980 Jan-Feb;3(1):178-83. doi: 10.2337/diacare.3.1.178.
10
Blood glucose and diabetes mellitus.血糖与糖尿病
Nutr Rev. 1971 Mar;29(3):64-6. doi: 10.1111/j.1753-4887.1971.tb07243.x.

引用本文的文献

1
The Human Genetic Variants CYP2J2 rs2280275 and EPHX2 rs751141 and Risk of Diabetic Nephropathy in Egyptian Type 2 Diabetic Patients.人类基因变体CYP2J2 rs2280275和EPHX2 rs751141与埃及2型糖尿病患者糖尿病肾病风险
Appl Clin Genet. 2020 Nov 19;13:165-178. doi: 10.2147/TACG.S281502. eCollection 2020.
2
A preliminary study of the relation between IL-4 and hypertension in type II diabetes mellitus.白细胞介素-4与2型糖尿病患者高血压之间关系的初步研究
Mol Biol Rep. 2018 Dec;45(6):1967-1972. doi: 10.1007/s11033-018-4349-7. Epub 2018 Sep 4.
3
Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications.

本文引用的文献

1
Studies on the heterogeneity of hemoglobin. V. Binding of hemoglobin with oxidized glutathione.血红蛋白异质性研究。V. 血红蛋白与氧化型谷胱甘肽的结合
J Lab Clin Med. 1962 Aug;60:302-19.
2
A new N-terminal blocking group involving a Schiff base in hemoglobin AIc.血红蛋白糖化终产物中涉及席夫碱的一种新的N端封闭基团。
Biochemistry. 1966 Aug;5(8):2489-503. doi: 10.1021/bi00872a002.
3
Studies of an unusual hemoglobin in patients with diabetes mellitus.糖尿病患者中一种异常血红蛋白的研究。
内皮型一氧化氮合酶（eNOS）基因G894T多态性与高血压风险及并发症的关联
Mol Cell Biochem. 2016 Oct;421(1-2):103-10. doi: 10.1007/s11010-016-2790-2. Epub 2016 Aug 24.
4
Fenugreek potent activity against nitrate-induced diabetes in young and adult male rats.葫芦巴对年轻和成年雄性大鼠硝酸盐诱导性糖尿病的有效作用。
Cytotechnology. 2015 May;67(3):437-47. doi: 10.1007/s10616-014-9702-7. Epub 2014 Mar 11.
5
Diabetic control in children and adolescents: Psychosocial factors and therapeutic efficacy.儿童和青少年糖尿病的控制：心理社会因素和治疗效果。
J Youth Adolesc. 1983 Apr;12(2):77-94. doi: 10.1007/BF02088306.
6
Association analysis of genetic variations of eNOS and α2β1 integrin genes with type 2 diabetic retinopathy.内皮型一氧化氮合酶（eNOS）和α2β1整合素基因的遗传变异与2型糖尿病视网膜病变的关联分析
Appl Clin Genet. 2012 Jul 24;5:55-65. doi: 10.2147/TACG.S31979. Print 2012.
7
Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy.水溶性姜黄素衍生物在实验性 1 型糖尿病伴心肌病中的信号转导机制。
Diabetol Metab Syndr. 2013 Mar 12;5(1):13. doi: 10.1186/1758-5996-5-13.
8
Glycosylated hemoglobins: a review.糖化血红蛋白：综述。
Can Fam Physician. 1983 Mar;29:564-8.
9
Glycosylated hemoglobin in fractions of erythrocytes of different ages.不同年龄红细胞组分中的糖化血红蛋白。
J Endocrinol Invest. 1993 Jul-Aug;16(7):495-8. doi: 10.1007/BF03348889.
10
Measuring glycosylated haemoglobin concentrations in a diabetic clinic.在糖尿病诊所测量糖化血红蛋白浓度。
Br Med J. 1980 Nov 22;281(6252):1394. doi: 10.1136/bmj.281.6252.1394.
Biochem Biophys Res Commun. 1969 Aug 22;36(5):838-43. doi: 10.1016/0006-291x(69)90685-8.
4
An abnormal hemoglobin in red cells of diabetics.糖尿病患者红细胞中的一种异常血红蛋白。
Clin Chim Acta. 1968 Oct;22(2):296-8. doi: 10.1016/0009-8981(68)90372-0.
5
Hemoglobin components in patients with diabetes mellitus.糖尿病患者的血红蛋白成分
N Engl J Med. 1971 Feb 18;284(7):353-7. doi: 10.1056/NEJM197102182840703.
6
Structure of hemoglobin AIc: nature of the N-terminal beta chain blocking group.血红蛋白A1c的结构：N端β链封闭基团的性质。
Biochem Biophys Res Commun. 1968 Jul 11;32(1):86-93. doi: 10.1016/0006-291x(68)90430-0.
7
Hemoglobin A1 C in childhood diabetes.儿童糖尿病中的糖化血红蛋白A1C
Metabolism. 1973 Feb;22(2):269-71. doi: 10.1016/0026-0495(73)90170-4.
8
Biochemistry of the renal glomerular basement membrane and its alterations in diabetes mellitus.肾小球基底膜的生物化学及其在糖尿病中的改变。
N Engl J Med. 1973 Jun 21;288(25):1337-42. doi: 10.1056/NEJM197306212882506.
9
Letter: Increased haemoglobin A1c and 2,3-diphosphoglycerate in diabetes and their effects on red-cell oxygen-releasing capacity.信函：糖尿病患者血红蛋白A1c和2,3-二磷酸甘油酸水平升高及其对红细胞氧释放能力的影响
Lancet. 1973 Nov 3;302(7836):1034. doi: 10.1016/s0140-6736(73)91132-x.
10
Red cell 2,3-diphosphoglycerate and diabetes.
Lancet. 1972 Apr 15;1(7755):843-4. doi: 10.1016/s0140-6736(72)90823-9.